ONO Pharmaceutical USA
Presence
ONO Pharmaceutical is one of the...
ONO Pharmaceutical is a company listed under the stock ticker 4528 (JP).
ONO Pharmaceutical has a direct presence in 2 countries.
Executives
View the org chart displaying its 3 main executives
Most searched biographies at ONO Pharmaceutical USA
- Kunihiko Ito, President and Chief Executive Officer
- David Trexler, Chief Commercial Officer
- Thomas Lechner, Vice President, Medical Affairs
Create your alert
to follow the executive moves at ONO Pharmaceutical USA.
Pharmaceuticals
ONO Pharmaceutical has 1,859 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by ONO Pharmaceutical USA
- ONO PHARMA USA Announces 2024 Golden Ticket Competition Now Accepting Applications from Innovative Startups | ONO Pharma USA, Inc.
- Newsroom | ONO Pharma USA, Inc.
- ONO PHARMA Announces Enrollment Is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL | ONO Pharma USA, Inc.
- ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University | ONO Pharma USA, Inc.
- Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins | ONO Pharma USA, Inc.
- ONO Selected as Highest Rating A-List Company by CDP in Two Categories of “Climate Change” and “Water Security” in CDP 2023 | ONO Pharma USA, Inc.
- Support for Disasters Caused by the 2024 Noto Peninsula Earthquake | ONO Pharma USA, Inc.
- Ono Enters into Collaboration Agreement with EVQLV to Generate Novel Antibodies against Multiple Targets Utilizing EVQLV’s AI-powered Antibody Design Engine for Development of Innovative Antibody Drugs | ONO Pharma USA, Inc.
- ONO Selected for the DJSI World Index and DJSI Asia Pacific Index for Four Straight Years | ONO Pharma USA, Inc.
- Ono Enters into a Drug Discovery Collaboration Agreement with Adimab to Discover Novel Antibody Drugs in the Oncology Field | ONO CORPORATEicon_search_whiteicon_close_wicon_search_g
- View more press releases Close
Social media about ONO Pharmaceutical USA
- ONO Pharmaceutical USA on Wikipedia, Google News & Yahoo Finance
- ONO Pharmaceutical USA on LinkedIn, Twitter & YouTube
